Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Guijarro · SciRah

Researcher profile · Semantic Scholar

F. Guijarro

Share profile

F. Guijarro — researcher profile on SciRah

h-index: 12
Works: 53
Citations: 379

Most-cited papers

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease
A. Bataller, G. Oñate, M. Díaz-Beyá, F. Guijarro +20 more
2020British Journal of Haematology47 citations Open access
Semantic Scholar
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
A. Bataller, A. Garrido, F. Guijarro, G. Oñate +29 more
2021Blood Advances44 citations Open access
Semantic Scholar
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
A. Oliver-Cáldes, R. Jimenez, M. Español-Rego, M. Cibeira +24 more
2021Journal for ImmunoTherapy of Cancer42 citations Open access
Semantic Scholar
Novel Tools for Diagnosis and Monitoring of AML
F. Guijarro, M. Garrote, N. Villamor, D. Colomer +2 more
2023Current Oncology30 citations Open access
Semantic Scholar
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study *
S. Kayser, R. Hills, Ralitsa Langova, M. Kramer +27 more
2021British Journal of Haematology26 citations Open access
Semantic Scholar
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
J. M. Cornet-Masana, A. Banús-Mulet, J. M. Carbó, M. A. Torrente +4 more
2019EBioMedicine25 citations Open access
Semantic Scholar
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes
S. Castaño-Díez, M. López-Guerra, Cristina Bosch-Castañeda, A. Bataller +15 more
2022Cancers19 citations Open access
Semantic Scholar
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
F. Guijarro, M. López-Guerra, Jordi Morata, A. Bataller +21 more
2023Blood Advances15 citations Open access
Semantic Scholar
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group
C. Jiménez-Vicente, P. Charry, S. Castaño-Díez, F. Guijarro +16 more
2024British Journal of Haematology13 citations
Semantic Scholar
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
Anna Carbó-Meix, F. Guijarro, Luo-Jun Wang, M. Grau +41 more
2023Haematologica13 citations Open access
Semantic Scholar
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow‐up of vacuolization and UBA1 clonal dynamics
J. Álamo, Lucía Mont-de Torres, S. Castaño-Díez, A. Mensa-Vilaró +20 more
2025British Journal of Haematology12 citations
Semantic Scholar
KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints
A. Bataller, F. Guijarro, Aurélie Caye-Eude, M. Strullu +21 more
2021Blood Advances12 citations Open access
Semantic Scholar
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study
I. Zugasti, M. López-Guerra, S. Castaño-Díez, D. Esteban +32 more
2025Experimental Hematology & Oncology11 citations Open access
Semantic Scholar
Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic
S. Castaño-Díez, H. Pomares, D. Esteban, F. Guijarro +16 more
2023British Journal of Haematology11 citations
Semantic Scholar
Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study
C. Jiménez-Vicente, Ares Guardia-Torrelles, A. Pérez-Valencia, A. Martínez-Roca +12 more
2024Annals of Hematology6 citations Open access
Semantic Scholar
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
M. Garrote, M. López-Guerra, J. García-Pagán, E. Arellano-Rodrigo +13 more
2024Annals of Hematology6 citations Open access
Semantic Scholar
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
C. Jiménez-Vicente, I. Arribas, H. Pomares, Guillermo Ramil +18 more
2025Haematologica5 citations Open access
Semantic Scholar
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing
M. Garrote, M. López-Guerra, E. Arellano-Rodrigo, M. Rozman +7 more
2023Cancers5 citations Open access
Semantic Scholar
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan
F. Guijarro, A. Bataller, M. Díaz-Beyá, A. Garrido +17 more
2022Bone Marrow Transplantation5 citations
Semantic Scholar
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
A. Martínez-Roca, C. Jiménez-Vicente, Beatriz Merchán, S. Castaño-Díez +14 more
2024Cancers4 citations
Semantic Scholar
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
S. Castaño-Díez, M. López-Guerra, I. Zugasti, X. Calvo +32 more
2024Blood Advances4 citations Open access
Semantic Scholar
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
L. Cuesta-Casanovas, J. Delgado-Martínez, J. M. Cornet-Masana, J. M. Carbó +4 more
2023Cancer Cell International4 citations Open access
Semantic Scholar
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications
F. Guijarro, S. Castaño-Díez, C. Jiménez-Vicente, M. Garrote +12 more
2024International Journal of Molecular Sciences3 citations Open access
Semantic Scholar
Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study
I. Zugasti, S. Castaño-Díez, D. Esteban, Alejandro Avendaño Pita +27 more
2023Blood3 citations Open access
Semantic Scholar
Caramel: Dual-targeting (CD123/CD33) CAR-T cell as a bridge to allogeneic transplantation for Relapsed/Refractory Acute Myeloid Leukemia. preclinical Results.
I. Zugasti, Vladimir Mulens-Arias, Lady Espinosa-Aroca, M. Vinyoles +21 more
2025Blood2 citations
Semantic Scholar
Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations
C. Jiménez-Vicente, Aina Cardús, Guillermo Ramil López, G. Oñate +22 more
2024Blood2 citations
Semantic Scholar
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
S. Castaño-Díez, J. Álamo, M. López-Guerra, Marta Gómez-Hernando +23 more
2024The Oncologist2 citations Open access
Semantic Scholar
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
C. Jiménez-Vicente, A. Martínez-Roca, H. Pomares, S. Castaño-Díez +14 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition
C. Jiménez-Vicente, M. Garrote, M. López-Guerra, Eva Villamon +11 more
2023Leukemia and Lymphoma2 citations
Semantic Scholar
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
Laura González-Guerrero, Helena Castellet, Clara Martínez, N. González +15 more
2025Diagnostic Pathology1 citations Open access
Semantic Scholar
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature
S. Castaño-Díez, F. Guijarro, M. López-Guerra, A. Pérez-Valencia +5 more
2024Cancers1 citations Open access
Semantic Scholar
Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA) Identify a High-Risk CMML Group Independent of Molecular-Cpss
S. Castaño-Díez, I. Zugasti, X. Calvo, Felicitas Schulz +30 more
2023Blood1 citations Open access
Semantic Scholar
P1356: CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
Lorenza Pérez Amill, Mercedes Armand Ugon, Sergio Alberto Peña Pérez, Maria Val Casals +23 more
2023HemaSphere1 citations Open access
Semantic Scholar
Whole Genome Sequencing of B-Cell Neoplasms with t(14;19)(q32;q13) Reveals Different Entities
Anna Carbó-Meix, F. Guijarro, Luo-Jun Wang, R. Royo +17 more
2021Blood1 citations Open access
Semantic Scholar
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity
J. M. Cornet-Masana, A. Banús-Mulet, L. Cuesta-Casanovas, J. M. Carbó +4 more
2020Journal of Cellular and Molecular Medicine1 citations Open access
Semantic Scholar
Rapid molecular screening of adult AML: Experience from the Spanish CETLAM cooperative group.
Helena Castellet, Anna Giné-Vilalta, M. Pratcorona, Guillermo Ramil +21 more
2026British Journal of Haematology0 citations
Semantic Scholar
Foamy cell infiltration as a morphological challenge: Histiocytosis versus plasma cell neoplasm
Carmen Rodriguez‐Miñón, Alberto Lázaro-García, F. Guijarro, S. Castaño-Díez +2 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults
S. Torres-Esquius, Maria Gabarrós-Subirà, María Eugenia Rivero, Guillermo Ramil López +14 more
2025Blood0 citations
Semantic Scholar
Validation of ELN 2022 Risk Classification in Patients Diagnosed with AML Undergoing Allogeneic Hematopoietic Cell Transplantation
C. Jiménez-Vicente, P. Charry, M. Suárez-Lledó, Beatriz Merchán Muñoz +18 more
2023Blood0 citations Open access
Semantic Scholar
PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS
Ares Guardia-Torrelles, C. Jiménez-Vicente, A. Roca, S. Castaño-Díez +10 more
2023HemaSphere0 citations Open access
Semantic Scholar
Topic: AS07-Singular Entities/Subtypes/AS07e-Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN): CLINICO-BIOLOGICAL CHARACTERISTICS AND OUTCOME OF 313 CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS INCLUDING 104 FORMERLY REFERRED TO AS OLIGOMONOCYTIC
S. Castaño-Díez, H. Pomares, C. Jiménez-Vicente, D. Esteban +19 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis0 citations
Semantic Scholar
P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS.
C. Jiménez-Vicente, F. Guijarro, M. López-Guerra, Ares Guardia-Torrelles +9 more
2023HemaSphere0 citations Open access
Semantic Scholar
P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
Marta Garrote Ordeig, M. López-Guerra, E. Arellano-Rodrigo, M. Rozman +7 more
2023HemaSphere0 citations Open access
Semantic Scholar
Clinical Characterization of Fusion Genes in Acute Myeloid Leukemia without Recurrent Genetic Abnormalities
F. Guijarro, M. Dabad, M. López-Guerra, Alex Bataller Torralba +12 more
2023Blood0 citations Open access
Semantic Scholar
Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation
C. Tolosa-Ridao, P. Charry, S. Castaño-Díez, M. Suárez-Lledó +16 more
2023Blood0 citations Open access
Semantic Scholar
P397: PROLACTIN RECEPTOR CONFERS CHEMORESISTANCE DUE TO SENESCENCE ENTRANCE IN ACUTE MYELOID LEUKEMIA
L. Cuesta-Casanovas, J. M. Cornet-Masana, J. M. Carbó, J. Delgado-Martínez +5 more
2022HemaSphere0 citations Open access
Semantic Scholar
P-008: First report of a patient with systemic light chain amyloidosis in the course of Multiple Myeloma treated with CAR T cells directed against B-cell maturation antigen
Aina Oliver Caldés, R. Jimenez, M. Español-Rego, M. Cibeira +21 more
2021Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Design and in Vitro Evaluation of a CAR-T Prototype (ARI-0003) Targeting CD123 for Acute Myeloid Leukemia
Alex Bataller Torralba, N. Tirado, D. Sánchez-Martínez, T. Velasco-Hernández +10 more
2021Blood0 citations
Semantic Scholar
Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)
À. Bataller, A. Garrido, F. Guijarro, M. Díaz-Beyá +22 more
20200 citations
Semantic Scholar
Myeloproliferative/Myelodysplastic Neoplasms Presenting All Diagnostic Criteria of Chronic Myelomonocytic Leukemia but with Absolute Peripheral Blood Monocytosis 0.5-1× 109/L Should be Classified As CMML
S. Castaño-Díez, M. López-Guerra, D. Esteban, F. Guijarro +8 more
20200 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Díaz-Beyá×31
Invite
M. Díaz-Beyá — researcher profile on SciRah
S. Castaño-Díez×29
Invite
S. Castaño-Díez — researcher profile on SciRah
M. López-Guerra×28
Invite
M. López-Guerra — researcher profile on SciRah
C. Jiménez-Vicente×25
Invite
C. Jiménez-Vicente — researcher profile on SciRah

Invite

D. Esteban — researcher profile on SciRah

Invite

I. Zugasti — researcher profile on SciRah

A. Martínez-Roca×16

Invite

A. Martínez-Roca — researcher profile on SciRah

Albert Cortés-Bullich×16

Invite

Albert Cortés-Bullich — researcher profile on SciRah

Jordi Esteve×15

Invite

Jordi Esteve — researcher profile on SciRah

Invite

M. Rozman — researcher profile on SciRah

Invite

D. Colomer — researcher profile on SciRah

Invite

J. Esteve — researcher profile on SciRah